Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: John R Resseger who wrote (1173)	2/3/1999 12:54:00 AM
From: Sir Auric Goldfinger	Respond to of 1476

penny stock that's what the dweebos have been reduced to.

To: John R Resseger who wrote (1173)	2/3/1999 8:15:00 AM
From: gammaray	Read Replies (1) \| Respond to of 1476

FWIW, Watching cnbc this morning while chugging away on my nordic trac. CEO of neurogen was guest. His company among 2 other biotechs got slammed in recent trading for missing crucial milestones. NRGN reported that their phase I trials did not significantly reduce anxiety. Well (in contrast)we've got a penny stock company that is sailing thru phase I in some pretty important areas. Has to bode well for antex as other biotechs miss the mark. fnews.yahoo.com Neil